CN219207505U - Prosthesis isolation structure for softening breast-augmentation prosthesis - Google Patents
Prosthesis isolation structure for softening breast-augmentation prosthesis Download PDFInfo
- Publication number
- CN219207505U CN219207505U CN202320313928.XU CN202320313928U CN219207505U CN 219207505 U CN219207505 U CN 219207505U CN 202320313928 U CN202320313928 U CN 202320313928U CN 219207505 U CN219207505 U CN 219207505U
- Authority
- CN
- China
- Prior art keywords
- prosthesis
- breast augmentation
- human body
- isolation
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002955 isolation Methods 0.000 title claims abstract description 49
- 230000003416 augmentation Effects 0.000 claims abstract description 37
- 210000000481 breast Anatomy 0.000 claims abstract description 37
- 238000010521 absorption reaction Methods 0.000 claims abstract description 32
- 239000008280 blood Substances 0.000 claims abstract description 30
- 210000004369 blood Anatomy 0.000 claims abstract description 30
- 238000000605 extraction Methods 0.000 claims abstract description 21
- 239000000463 material Substances 0.000 claims description 7
- 239000011248 coating agent Substances 0.000 claims description 6
- 238000000576 coating method Methods 0.000 claims description 6
- 102000008186 Collagen Human genes 0.000 claims description 3
- 108010035532 Collagen Proteins 0.000 claims description 3
- 108091005804 Peptidases Proteins 0.000 claims description 3
- 229920000954 Polyglycolide Polymers 0.000 claims description 3
- 239000004365 Protease Substances 0.000 claims description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 3
- 229920001436 collagen Polymers 0.000 claims description 3
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 3
- 239000004633 polyglycolic acid Substances 0.000 claims description 3
- 239000004626 polylactic acid Substances 0.000 claims description 3
- 101000928792 Drosophila melanogaster Death-associated inhibitor of apoptosis 1 Proteins 0.000 claims description 2
- 230000037431 insertion Effects 0.000 claims 1
- 238000003780 insertion Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 8
- 239000012528 membrane Substances 0.000 abstract description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- 210000000038 chest Anatomy 0.000 description 6
- 239000002775 capsule Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 206010067484 Adverse reaction Diseases 0.000 description 3
- 230000006838 adverse reaction Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 210000004883 areola Anatomy 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02W—CLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO WASTEWATER TREATMENT OR WASTE MANAGEMENT
- Y02W90/00—Enabling technologies or technologies with a potential or indirect contribution to greenhouse gas [GHG] emissions mitigation
- Y02W90/10—Bio-packaging, e.g. packing containers made from renewable resources or bio-plastics
Landscapes
- Prostheses (AREA)
Abstract
The utility model relates to the technical field of breast augmentation of prostheses and discloses a prosthesis isolation structure for softening a breast augmentation prosthesis, which comprises a human body absorption membrane layer, wherein the human body absorption membrane layer can be absorbed by human body tissues, the human body absorption membrane layer surrounds to form an isolation bag, the isolation bag is used for wrapping the breast augmentation prosthesis, a blood extraction layer is coated on the human body absorption membrane layer, and the blood extraction layer is positioned on the outer wall of the isolation bag. The prosthesis is isolated from human tissues, so that the forming quality of the envelope is better and softer, the prosthesis is softer, and the effect of the breast augmentation operation of the prosthesis is improved.
Description
Technical Field
The utility model relates to the technical field of breast augmentation of prostheses, in particular to a prosthesis isolation structure for softening a breast augmentation prosthesis.
Background
With the continuous development of the technology level and the medical technology, the shape and the size of the chest are changed by breast augmentation, and the breast augmentation is one of the operations implemented by plastic and cosmetic institutions. Three common surgical incisions for breast augmentation are selected: armpit incisions, areola incisions, inframammary fold incisions. The current common breast augmentation operation is 3 kinds, namely prosthesis breast augmentation operation, autologous fat transplantation breast augmentation operation and injection breast augmentation operation; the prosthesis breast augmentation operation is most widely applied, in the prosthesis breast augmentation operation, a proper implant prosthesis is needed to be firstly selected, then a proper cavity is stripped in a chest cavity according to the size of the prosthesis, then the prosthesis is implanted in the cavity, human tissues in the cavity surround the prosthesis to form a coating, the softness of the coating directly influences the softness of the prosthesis, at present, the prosthesis is directly implanted in the cavity, the prosthesis is used as non-human tissues, and a certain rejection reaction is generated with the human tissues in the cavity, so that the coating has poor formation quality, further the coating and the prosthesis have poor softness, the chest feel after operation is hard, and the breast augmentation effect of the prosthesis is influenced.
Disclosure of Invention
The utility model aims to overcome the defects of the prior art, and provides a prosthesis isolation structure for softening a breast augmentation prosthesis, which isolates the prosthesis from human tissues, so that the formation quality of an envelope is better and softer, the prosthesis is softer, and the effect of the breast augmentation operation of the prosthesis is improved.
The aim of the utility model is realized by the following technical scheme: the utility model provides a make soft prosthetic isolation structure of breast augmentation prosthesis, includes the human absorption rete, the human absorption rete can be absorbed by human tissue, the human absorption rete encircles and forms the isolation bag, the isolation bag is used for wrapping up breast augmentation prosthesis, the coating has the blood extraction layer on the human absorption rete, the blood extraction layer is located the outer wall of isolation bag.
The technical scheme has the advantages that the human tissues and the prosthesis are isolated through the human absorption film layer, so that the human tissues in the cavity are not contacted with the prosthesis to generate rejection reaction, the blood extraction layer is derived from the extract of the blood of an operator, the extract of the blood of the operator is smeared on the isolation bag, on one hand, the human absorption film layer is isolated, on the other hand, the formation of the film is facilitated, the film is better and softer, after the film is formed, the human absorption film layer is also approximately absorbed by the human body, the prosthesis is exposed in the cavity, at the moment, the human tissues are isolated from the prosthesis through the film, the prosthesis is prevented from being directly contacted with the human tissues, the soft film wraps the prosthesis, the prosthesis is also softened, the chest after operation is softer, adverse reaction is not generated after the operation, and the effect of the breast-augmentation operation of the prosthesis is improved.
In some embodiments, the isolation pouch is provided with an opening for placement of a breast augmentation prosthesis.
The technical scheme has the advantages that the prosthesis is conveniently placed into the isolation bag through the opening of the isolation bag, so that the prosthesis is separated from human tissues in the cavity through the isolation bag, and the soft envelope is formed.
In some embodiments, the opening of the isolation pouch is sewn with a protein thread that is absorbable by the human body.
The technical scheme has the advantages that the opening of the isolation bag is sewn, so that the prosthesis can be effectively prevented from falling from the isolation bag, the protein line can be absorbed by a human body, and the prosthesis can be ensured to fall into the cavity smoothly after the envelope is formed and be wrapped by the envelope.
In some embodiments, the human body absorption film layer is made of collagen film, polylactic acid material or polyglycolic acid material.
The technical scheme has the advantages that the human body is gradually absorbed by the human body in the absorption membrane layer, so that the formation of the envelope is facilitated, and the problem that the isolation bag needs to be taken out again after operation is avoided.
In some embodiments, the blood extraction layer is made using PRP or protease.
The technical scheme has the advantages that the extract from the blood of the operator cannot react with human tissues in the lacunae in a rejection way, so that the formation of the envelope is facilitated, and the softness of the envelope is improved.
In some embodiments, the blood extraction layer is applied at a thickness of no more than 5mm.
The technical scheme has the advantages that the blood extraction layer is prevented from being smeared too thick, the digestion time of the blood extraction layer is prolonged, the prosthesis can fall into the cavity to be wrapped by the capsule after the capsule is formed, the implanted prosthesis is softer, and the effect of the breast augmentation operation of the prosthesis is improved.
The beneficial effects of the utility model are as follows:
the human body tissues and the prosthesis are isolated through the human body absorption film layer, so that the human body tissues in the cavity are not contacted with the prosthesis to generate rejection reaction, the blood extraction layer is from an extract of the blood of an operator, the extract of the blood of the operator is smeared on the isolation bag, on one hand, the human body absorption film layer is isolated, on the other hand, the formation of the film is facilitated, the film is better and softer in quality, and after the film is formed, the human body absorption film layer is also absorbed by the human body, so that the prosthesis is exposed in the cavity, at the moment, the human body tissues are isolated from the prosthesis through the film, the prosthesis is prevented from being directly contacted with the human body tissues, and the soft film wraps the prosthesis to soften the prosthesis, so that the chest after operation is softer, the adverse reaction cannot be generated after the operation, and the effect of the breast-augmentation operation of the prosthesis is improved.
Drawings
FIG. 1 is a perspective view of a prosthesis isolation structure for softening a breast augmentation prosthesis of the present utility model;
FIG. 2 is a hierarchical structure diagram of a prosthesis isolation structure for softening a breast augmentation prosthesis according to the present utility model;
in the figure, the membrane layer is absorbed by a human body, the bag is isolated by a 2-way, and the blood is extracted by a 3-way.
Description of the embodiments
The technical solution of the present utility model will be described in further detail with reference to the accompanying drawings, but the scope of the present utility model is not limited to the following description.
As shown in fig. 1 and 2, the prosthesis isolation structure for softening the breast augmentation prosthesis comprises a human body absorption film layer 1, wherein the human body absorption film layer 1 can be absorbed by human body tissues, the human body absorption film layer 1 is surrounded to form an isolation bag 2, the isolation bag 2 is used for wrapping the breast augmentation prosthesis, the human body tissues and the prosthesis are isolated through the human body absorption film layer 1, so that the human body tissues in a cavity cannot contact with the prosthesis to generate rejection reaction, the human body absorption film layer 1 is coated with a blood extraction layer 3, and the blood extraction layer 3 is positioned on the outer wall of the isolation bag 2; the softness of the implanted prosthesis is not greatly related to the softness of the prosthesis, and mainly depends on the softness of the envelope, the prosthesis can be wrapped after the envelope is formed, and when the envelope is soft, the prosthesis can be soft after being wrapped, so that the softness of the chest of the prosthesis after breast augmentation is mainly dependent on the softness of the envelope; the blood extraction layer 3 is from the extract of the blood of the operator, the extract of the blood of the operator is smeared on the isolation bag 2, on one hand, the human body absorption membrane layer 1 is isolated, on the other hand, the formation of the envelope is facilitated, so that the quality of the envelope is better and softer, after the envelope is formed, the human body absorption membrane layer 1 is also absorbed by the human body, so that the prosthesis is exposed in the cavity, at the moment, the human body tissue is isolated from the prosthesis through the envelope, the prosthesis is prevented from directly contacting the human body tissue, and the soft envelope wraps the prosthesis, so that the prosthesis is also softened, the chest after the operation is softer, adverse reactions are not generated after the operation, and the effect of the prosthesis breast augmentation operation is improved.
In some embodiments, as shown in fig. 1, an opening for placing the breast-augmentation prosthesis is formed in the isolation bag 2, the prosthesis is conveniently placed in the isolation bag 2 through the opening of the isolation bag 2, so that the prosthesis is separated from human tissues in the cavity by the isolation bag 2, a soft envelope is formed, the opening of the isolation bag 2 is sewed by protein wires which can be absorbed by a human body, after the prosthesis is placed in the isolation bag 2, the opening of the isolation bag 2 is sewed by the protein wires, the opening of the isolation bag 2 is sewed, the prosthesis can be effectively prevented from falling from the isolation bag 2, the protein wires can be absorbed by the human body, and the prosthesis can be ensured to smoothly fall into the cavity to be wrapped by the envelope after the envelope is formed.
In some embodiments, as shown in fig. 2, the human body absorption film layer 1 is made of a material capable of being absorbed by a human body, for example, the human body absorption film layer 1 is made of a collagen film, a polylactic acid material or a polyglycolic acid material, in the forming process of the envelope, the human body absorption film layer 1 is gradually absorbed by the human body, and the forming time of the envelope is shorter than the thorough absorbing time of the human body absorption film layer 1, so that when the prosthesis is exposed in the cavity, the envelope is formed, and the prosthesis is wrapped by the envelope;
furthermore, the blood extraction layer 3 is made of PRP or protease, and can be separated by a medical centrifuge, so that the extract from the blood of the operator can not react with human tissues in the lacunae, thereby being beneficial to forming the envelope and improving the softness of the envelope; the smearing thickness of the blood extraction layer 3 is not more than 5mm, so that the blood extraction layer 3 is prevented from being smeared too much, the digestion time of the blood extraction layer 3 is prolonged, the prosthesis can fall into the cavity to be wrapped by the capsule after the capsule is formed, the implanted prosthesis is softer, and the breast augmentation operation effect of the prosthesis is improved.
In the description of the present utility model, it should be understood that the terms "coaxial," "bottom," "one end," "top," "middle," "other end," "upper," "one side," "top," "inner," "front," "center," "two ends," etc. indicate orientations or positional relationships based on the orientation or positional relationships shown in the drawings, are merely for convenience in describing the present utility model and simplifying the description, and do not indicate or imply that the devices or elements referred to must have a specific orientation, be configured and operated in a specific orientation, and thus should not be construed as limiting the present utility model; and those of ordinary skill in the art will appreciate that the benefits achieved by the present utility model are merely better than those achieved by the current embodiments of the prior art in certain circumstances and are not intended to be the most excellent uses directly in the industry.
The foregoing is merely a preferred embodiment of the utility model, and it is to be understood that the utility model is not limited to the form disclosed herein but is not to be construed as excluding other embodiments, but is capable of numerous other combinations, modifications and environments and is capable of modifications within the scope of the inventive concept, either as taught or as a matter of routine skill or knowledge in the relevant art. And that modifications and variations which do not depart from the spirit and scope of the utility model are intended to be within the scope of the appended claims.
Claims (6)
1. The utility model provides a make soft prosthetic isolation structure of breast augmentation prosthesis, its characterized in that, including human absorption rete (1), human absorption rete (1) can be absorbed by human tissue, human absorption rete (1) encircle and form isolation bag (2), isolation bag (2) are used for wrapping up breast augmentation prosthesis, coating has blood extraction layer (3) on human absorption rete (1), blood extraction layer (3) are located the outer wall of isolation bag (2).
2. A prosthesis isolation structure for softening a breast augmentation prosthesis according to claim 1, wherein said isolation bag (2) is provided with an opening for the insertion of the breast augmentation prosthesis.
3. A prosthetic isolation structure for softening a breast augmentation prosthesis according to claim 2, characterized in that the opening of said isolation pouch (2) is sewn with a protein thread absorbable by the human body.
4. The prosthesis isolation structure for softening a breast augmentation prosthesis according to claim 1, wherein the human body absorption film layer (1) is made of collagen film, polylactic acid material or polyglycolic acid material.
5. A prosthesis isolation structure for softening a breast augmentation prosthesis according to claim 4, wherein said blood extraction layer (3) is made of PRP or protease.
6. A prosthesis isolation structure for softening a breast augmentation prosthesis according to claim 5, characterized in that the blood extraction layer (3) is applied in a thickness of not more than 5mm.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202320313928.XU CN219207505U (en) | 2023-02-26 | 2023-02-26 | Prosthesis isolation structure for softening breast-augmentation prosthesis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202320313928.XU CN219207505U (en) | 2023-02-26 | 2023-02-26 | Prosthesis isolation structure for softening breast-augmentation prosthesis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN219207505U true CN219207505U (en) | 2023-06-20 |
Family
ID=86758521
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202320313928.XU Active CN219207505U (en) | 2023-02-26 | 2023-02-26 | Prosthesis isolation structure for softening breast-augmentation prosthesis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN219207505U (en) |
-
2023
- 2023-02-26 CN CN202320313928.XU patent/CN219207505U/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4470160A (en) | Cast gel implantable prosthesis | |
| US4840628A (en) | Non-enveloped gel prosthesis | |
| CN103393482B (en) | A kind of mammary prostheses supporting device based on tissue matrix material and preparation method thereof | |
| KR20220079816A (en) | Container device for breast implants for reconstructive breast surgery | |
| US6371984B1 (en) | Implantable prosthetic or tissue expanding device | |
| US4298998A (en) | Breast prosthesis with biologically absorbable outer container | |
| US4428082A (en) | Breast prosthesis with filling valve | |
| US9913711B2 (en) | Internal long term absorbable matrix brassiere | |
| JP5646704B2 (en) | Medical implant assembly having an interface | |
| GB2046098A (en) | Prosthetic device | |
| WO2012044997A2 (en) | Kits, components and methods for tissue reconstruction | |
| CN219207505U (en) | Prosthesis isolation structure for softening breast-augmentation prosthesis | |
| HARTLEY | Specific applications of the double lumen prosthesis | |
| US11672995B2 (en) | Shape memory material-based minimally invasive implantation with multi-axis curl self-expanding structure | |
| CN203447388U (en) | Breast prosthesis support device based on tissue matrix materials | |
| Hodgkinson | Buckled upper pole breast style 410 implant presenting as a manifestation of capsular contraction | |
| JP2000126211A (en) | Implant body holder | |
| CN210354991U (en) | Eyebrow arch prosthesis | |
| CN100358476C (en) | Micro wound beauty needle for human breast, hipshot and face and its useage | |
| RU2647154C1 (en) | Method of surgical formation of the areola and nipple on the mammary gland | |
| CN209695312U (en) | It is a kind of for taking out the stripper of breast prosthesis | |
| CN110338941A (en) | A kind of compound artificial eye holder and preparation method thereof | |
| CN209629758U (en) | It is a kind of for taking out the elastic separating plier of breast prosthesis | |
| CN2624854Y (en) | Injection silicon rubber mammary prosthesis | |
| CN220046188U (en) | Buttock silica gel prosthesis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CB03 | Change of inventor or designer information | ||
| CB03 | Change of inventor or designer information |
Inventor after: Sun Meiyang Inventor after: Yin Xianghua Inventor before: Yin Xianghua |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20240814 Address after: No. 16, Group 4, Liansheng Gaota Village, Tashan Town, Santai County, Mianyang City, Sichuan Province 621000 Patentee after: Pu Anping Country or region after: China Address before: No. 1, 3rd Floor, No. 703 Tianfu 1st Street, Chengdu High tech Zone, China (Sichuan) Pilot Free Trade Zone, Chengdu City, Sichuan Province, 610000 Patentee before: Chengdu Gaoxin Baiwei Medical Beauty Clinic Co.,Ltd. Country or region before: China |